Chest Injury Trauma BluntCTSNCT06737575
Chest Trauma Scoring Systems as Predictors of Morbidity and Mortality in Iraq
An observational study of Chest Injury Trauma Blunt, run by Al-Nahrain University at 1 site in Iraq.
Trial summary
This prospective observational study aims to evaluate the effectiveness of chest trauma scoring systems in predicting morbidity and mortality in patients with blunt chest trauma in Iraq. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Chest Injury Trauma Blunt
- How many people
- 190 participants
- Where
- 1 siteIraq
- Study dates
- 20 Apr 2025to 30 Jun 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population will consist of adult patients aged 18 years and older presenting to the emergency department with blunt chest trauma. Participants will be assessed using the Chest Trauma Score (CTS) to predict morbidity and mortality, and data on demographics, injury mechanisms, and clinical outcomes will be collected. The study aims to include a diverse sample from varying age groups and both genders to evaluate the score's performance across different subgroups.
Who may be able to join
- Patients diagnosed with blunt chest trauma.
- Patients presenting to the emergency department within 4 hours.
- Patients (or their legal representatives) must provide informed consent to participate in the study.
- Patients who can be assessed using the Chest Trauma Score at the time of arrival (e.g., having stable enough vitals to allow for evaluation).
Who cannot join
- Patients with penetrating chest trauma (e.g., gunshot or stab wounds), as the Chest Trauma Score is typically used for blunt trauma.
- Patients presenting with chest conditions unrelated to trauma (e.g., pneumonia, COPD exacerbation, or other non-traumatic causes of chest pain or respiratory distress).
- Patients with severe pre-existing comorbidities (e.g., end-stage heart failure, terminal cancer) where trauma is unlikely to be the primary cause of morbidity or mortality.
- Patients with missing or incomplete clinical data, including imaging or vital signs necessary to calculate the CTS accurately.
- Patients who refuse consent or do not agree to the use of their data for research purposes.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Iraq1 site
College of Medicine - Al-Nahrain University
Baghdad
Yaser aamer Eisa Alhaibi, Assistant professor, 009647705051684, yaseraamer@nahrainuniv.edu.iq
Abdul-Ilah R. Khamis
About this study
Official title: Validation of Chest Trauma Scoring Systems in Predicting Blunt Chest Injury Outcomes in Iraq: A Prospective Study
This prospective observational study aims to evaluate the effectiveness of chest trauma scoring systems in predicting morbidity and mortality in patients with blunt chest trauma in Iraq. The primary questions it seeks to address are:
How accurately do chest trauma scoring systems predict mortality and critical outcomes such as ICU admission or the need for advanced interventions? How well do these scoring systems stratify patients based on injury severity in a resource-limited setting? Are there any demographic or clinical factors that impact the predictive performance of these scoring systems?
Read more
Participants will:
Be assessed using chest trauma scoring systems upon arrival at the emergency department to determine risk levels.
Have demographic and clinical data, including age, gender, injury mechanism, comorbidities, and length of hospital stay, collected to explore potential associations with outcomes.
Read the detailed description
Chest trauma is a major cause of morbidity and mortality, often resulting from motor vehicle accidents, falls, or physical assaults. It can lead to serious complications such as pulmonary contusions, rib fractures, and damage to thoracic organs. The Chest Trauma Score (CTS) helps assess injury severity by considering factors like age, number of rib fractures, and pulmonary contusion severity. Higher CTS values are associated with worse outcomes, such as prolonged mechanical ventilation and higher mortality rates. Early identification using this scoring system improves clinical decision-making and outcomes.
Despite the global utility of trauma scoring systems, there is limited research on their application in developing countries like Iraq, where trauma care is often constrained by limited resources and inconsistent protocols. In Iraq, blunt chest trauma is a prevalent issue due to frequent road traffic accidents and other causes. However, a lack of locally validated tools such as CTS hinders the ability of healthcare providers to assess injury severity accurately and predict outcomes.
This study aims to evaluate the effectiveness of the Chest Trauma Score in predicting morbidity and mortality among patients with blunt chest trauma in Iraq. By addressing this research gap, the findings will contribute to improving trauma care protocols, informing policy decisions, and enhancing the overall healthcare system's capacity to manage chest trauma effectively.
- Conditions
- Chest Injury Trauma Blunt
- Keywords
- CTS, Trauma
- Medical subject headings
- Wounds and Injuries
What is being measured
The primary outcome is the main question the study is designed to answer.
In hospital mortality
Mortality (death) during hospitalization.
Measured: In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 30
Accuracy Assessment of the Chest Trauma Score (CTS)
The total score ranges from 2 to 12, with higher scores indicating worse outcomes.
Measured: the first 4 hours after ER admission
Secondary outcomes (1)
Number of Participants Requiring ICU Admission
The requirement for admission to the intensive care unit (ICU) is determined by the presence of severe clinical deterioration, significant complications, or the need for advanced monitoring and life-support measures.
Measured: Up to discharge, an average of 10 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Dec 2024
- Study start20 Apr 2025 (estimated)
- Primary completion10 Jun 2025 (estimated)
- Study completion30 Jun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Chest Injury Trauma BluntStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 190 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Al-Nahrain University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Abdul-Ilah R. Khamis, Al-Nahrain University
- Investigators
- Yaser aamer Eisa Alhaibi, Assistant professor, Study director, College Of Medicine - Nahrain University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06737575
- Sponsor's protocol ID
- UNCOMIRB20241212A
- Other IDs
- 013
- Acronym
- CTS
- Status last verified
- Mar 2025
- First submitted
- 12 Dec 2024
- Last updated
- 19 Mar 2025
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- No
Publications
Battle C, Cole E, Carter K, Baker E. Clinical prediction models for the management of blunt chest trauma in the emergency department: a systematic review. BMC Emerg Med. 2024 Oct 12;24(1):189. doi: 10.1186/s12873-024-01107-6.
PubMed 39395934Dogrul BN, Kiliccalan I, Asci ES, Peker SC. Blunt trauma related chest wall and pulmonary injuries: An overview. Chin J Traumatol. 2020 Jun;23(3):125-138. doi: 10.1016/j.cjtee.2020.04.003. Epub 2020 Apr 20.
PubMed 32417043
Study at a glance
From the registry record, last updated by the sponsor on 19 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validation of Chest Trauma Scoring Systems in Predicting Blunt Chest Injury Outcomes in Iraq: A Prospective Study
- ClinicalTrials.gov ID
- NCT06737575
- Acronym / sponsor ID
- CTS / UNCOMIRB20241212A
- Conditions
- Chest Injury Trauma Blunt
- Keywords
- CTS, Trauma
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 190 participants (estimated)
- Lead sponsor
- Al-Nahrain UniversityUniversity, hospital or other
- Study start
- 20 Apr 2025 (estimated)
- Primary completion
- 10 Jun 2025 (estimated)
- Study completion
- 30 Jun 2025 (estimated)
- First posted
- 17 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This prospective observational study aims to evaluate the effectiveness of chest trauma scoring systems in predicting morbidity and mortality in patients with blunt chest trauma in Iraq. The primary questions it seeks to address are:
How accurately do chest trauma scoring systems predict mortality and critical outcomes such as ICU admission or the need for advanced interventions? How well do these scoring systems stratify patients based on injury severity in a resource-limited setting? Are there any demographic or clinical factors that impact the predictive performance of these scoring systems?
Participants will:
Be assessed using chest trauma scoring systems upon arrival at the emergency department to determine risk levels.
Have demographic and clinical data, including age, gender, injury mechanism, comorbidities, and length of hospital stay, collected to explore potential associations with outcomes.
Detailed description
Chest trauma is a major cause of morbidity and mortality, often resulting from motor vehicle accidents, falls, or physical assaults. It can lead to serious complications such as pulmonary contusions, rib fractures, and damage to thoracic organs. The Chest Trauma Score (CTS) helps assess injury severity by considering factors like age, number of rib fractures, and pulmonary contusion severity. Higher CTS values are associated with worse outcomes, such as prolonged mechanical ventilation and higher mortality rates. Early identification using this scoring system improves clinical decision-making and outcomes.
Despite the global utility of trauma scoring systems, there is limited research on their application in developing countries like Iraq, where trauma care is often constrained by limited resources and inconsistent protocols. In Iraq, blunt chest trauma is a prevalent issue due to frequent road traffic accidents and other causes. However, a lack of locally validated tools such as CTS hinders the ability of healthcare providers to assess injury severity accurately and predict outcomes.
This study aims to evaluate the effectiveness of the Chest Trauma Score in predicting morbidity and mortality among patients with blunt chest trauma in Iraq. By addressing this research gap, the findings will contribute to improving trauma care protocols, informing policy decisions, and enhancing the overall healthcare system's capacity to manage chest trauma effectively.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population will consist of adult patients aged 18 years and older presenting to the emergency department with blunt chest trauma. Participants will be assessed using the Chest Trauma Score (CTS) to predict morbidity and mortality, and data on demographics, injury mechanisms, and clinical outcomes will be collected. The study aims to include a diverse sample from varying age groups and both genders to evaluate the score's performance across different subgroups.
Key inclusion criteria (4 listed)
- Patients diagnosed with blunt chest trauma.
- Patients presenting to the emergency department within 4 hours.
- Patients (or their legal representatives) must provide informed consent to participate in the study.
- Patients who can be assessed using the Chest Trauma Score at the time of arrival (e.g., having stable enough vitals to allow for evaluation).
Key exclusion criteria (5 listed)
- Patients with penetrating chest trauma (e.g., gunshot or stab wounds), as the Chest Trauma Score is typically used for blunt trauma.
- Patients presenting with chest conditions unrelated to trauma (e.g., pneumonia, COPD exacerbation, or other non-traumatic causes of chest pain or respiratory distress).
- Patients with severe pre-existing comorbidities (e.g., end-stage heart failure, terminal cancer) where trauma is unlikely to be the primary cause of morbidity or mortality.
- Patients with missing or incomplete clinical data, including imaging or vital signs necessary to calculate the CTS accurately.
- Patients who refuse consent or do not agree to the use of their data for research purposes.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
In hospital mortality
Time frame: In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 30
Mortality (death) during hospitalization.
Accuracy Assessment of the Chest Trauma Score (CTS)
Time frame: the first 4 hours after ER admission
The total score ranges from 2 to 12, with higher scores indicating worse outcomes.
1 secondary outcome
Number of Participants Requiring ICU Admission
Time frame: Up to discharge, an average of 10 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Mar 2025.
- Results publication: PubMed 39395934Battle C, Cole E, Carter K, Baker E. Clinical prediction models for the management of blunt chest trauma in the emergency department: a systematic review. BMC Emerg Med. 2024 Oct 12;24(1):189. doi: 10.1186/s12873-024-01107-6.
- Results publication: PubMed 32417043Dogrul BN, Kiliccalan I, Asci ES, Peker SC. Blunt trauma related chest wall and pulmonary injuries: An overview. Chin J Traumatol. 2020 Jun;23(3):125-138. doi: 10.1016/j.cjtee.2020.04.003. Epub 2020 Apr 20.
- Individual participant dataSharing planned: No
Related trials for Chest Injury Trauma Blunt
Not yet recruitingObservational study
Medical,Nursing Record,PE, Blood Test and Radiological Examination ,Morality and Mobility of Multiple Trauma Patient
Trauma Centers/Statistics & Numerical Data, Trauma Blunt
Active, not recruiting
Effectiveness of an Innovative Chest Stabilizer in Rib Fracture Treatment: Impact on Respiratory Function, Complications, and Clinical Outcomes
Rib Fractures, Blunt Chest Trauma
RecruitingObservational study
GNRI and PNI for Predicting Short-Term Outcomes in Older Adults With Multiple Rib Fractures
Multiple Rib Fractures, Isolated Blunt Thoracic Trauma
Not yet recruitingObservational study
Combined Lung and Diaphragmatic Ultrasound to Predict Respiratory Failure in Blunt Chest Trauma
Blunt Chest Trauma, Respiratory Failure
Active, not recruitingObservational study
Blunt Traumatic Aortic Injury
Blunt Traumatic Aortic Injury, BTAI
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Yaser aamer Eisa Alhaibi, Assistant professor study director
College Of Medicine - Nahrain University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chest Injury Trauma Blunt, run by Al-Nahrain University at 1 site in Iraq.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 19 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Abdul-Ilah R. Khamis (+9647838571013, allaabed987@ced.nahrainuniv.edu.iq), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
In hospital mortality (time frame: In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 30). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06737575, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2025.